2012-10-10 09:17:57 - New Pharmaceuticals market report from Global Markets Direct: "Aphios Corporation - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Aphios Corporation - Product Pipeline Review - 2012" provides data on the Aphios Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Aphios Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Aphios Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Aphios Corporation - Brief Aphios Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Aphios Corporation human therapeutic division.
*

Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Aphios Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Aphios Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468505_aphios_corporation_product_pipeline_r ..


Reasons to buy

* Evaluate Aphios Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Aphios Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Aphios Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Aphios Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Aphios Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Aphios Corporation Snapshot
Aphios Corporation Overview
Key Information
Key Facts
Aphios Corporation - Research and Development Overview
Key Therapeutic Areas
Aphios Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Aphios Corporation - Pipeline Products Glance
Aphios Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Aphios Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Aphios Corporation - Drug Profiles
APH-0701
Product Description
Mechanism of Action
R&D Progress
APH-0703
Product Description
Mechanism of Action
R&D Progress
APH-0812
Product Description
Mechanism of Action
R&D Progress
APH-0912
Product Description
Mechanism of Action
R&D Progress
APH-M-109
Product Description
Mechanism of Action
R&D Progress
APP-0206s
Product Description
Mechanism of Action
R&D Progress
APP-0303s
Product Description
Mechanism of Action
R&D Progress
APP-0401s
Product Description
Mechanism of Action
R&D Progress
Asterias
Product Description
Mechanism of Action
R&D Progress
Betulinic Acid
Product Description
Mechanism of Action
R&D Progress
Bryosomes
Product Description
Mechanism of Action
R&D Progress
Camposomes
Product Description
Mechanism of Action
R&D Progress
CXF-Y2
Product Description
Mechanism of Action
R&D Progress
Delta 9-THC
Product Description
Mechanism of Action
R&D Progress
Delta 9-THCA
Product Description
Mechanism of Action
R&D Progress
Dermos
Product Description
Mechanism of Action
R&D Progress
docetaxel
Product Description
Mechanism of Action
R&D Progress
frondoside A
Product Description
Mechanism of Action
R&D Progress
Hyperforin
Product Description
Mechanism of Action
R&D Progress
Hypericin
Product Description
Mechanism of Action
R&D Progress
Marinus
Product Description
Mechanism of Action
R&D Progress
paclitaxel
Product Description
Mechanism of Action
R&D Progress
sperol
Product Description
Mechanism of Action
R&D Progress
Zindol
Product Description
Mechanism of Action
R&D Progress
Aphios Corporation - Pipeline Analysis
Aphios Corporation - Pipeline Products by Therapeutic Class
Aphios Corporation - Pipeline Products by Route of Administration
Aphios Corporation - Pipeline Products By Mechanism of Action
Aphios Corporation - Recent Pipeline Updates
Aphios Corporation - Dormant Projects
Aphios Corporation - Locations And Subsidiaries
Head Office
Aphios Corporation, Recent Developments
Aphios Corporation- Press Release
Jan 24, 2012: Aphios Receives Phase II SBIR Grant From National Institute On Aging For Alzheimer's Disease Research

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468505&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.